Website: WWW.TAURIGUM.COM

NEW YORK, NY, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, is pleased to announce that it has officially launched its E-Commerce site (the “Website”) for the sale of its CBD Infused chewing gum (“CBD Gum” or “Tauri-Gum™”). The E-Commerce site can be accessed by typing in the following URL Website Address (www.taurigum.com).  The Company is currently selling both its Tauri-Gum™ individual blister pack ($17.99 per unit) and retail display box ($179.99 per unit); shipping is free for any customer that orders 2 or more individual blister packs. The Company is currently finalizing the Website’s back-end configuration (payment processing capability) and expects to start processing customer orders over the next few days.  The Company has also established a reliable and efficient fulfillment infrastructure and anticipates that its initial Tauri-Gum™ inventory (8,700 individual blister packs) will be received - at Tauriga’s fulfillment facility - within the next week or so. 

Over the past few days, the Company has continued to meet with top tier prospective distribution companies and believes that Tauri-Gum™ may represent a high quality/low risk entry into the CBD market (for such distribution firms).  The Company can also confirm that it expects to commence generating revenue during this current month (March 2019). 

Direct Link to Tauri-Gum™ Shop & Checkout: https://taurigum.com/new-products

ABOUT: TAURIGA SCIENCES, INC.

Tauriga Sciences, Inc. (TAUG) is engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-GumTMSee also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.

In addition, the Company is currently constructing an E-Commerce site for the sale of its CBD Infused Chewing Gum.  This site is being constructed under the following URL address:  www.taurigum.com

Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY  10022
Chief Executive Officer
Mr. Seth M. Shaw
Email:  sshaw@tauriga.com
cell # (917) 796 9926
www.tauriga.com